Iron Increases Diabetes-induced Kidney Injury and Oxidative Stress in Rats
Overview
Authors
Affiliations
Diabetic nephropathy is both a common and a severe complication of diabetes mellitus. Iron is an essential trace element. However, excess iron is toxic, playing a role in the pathogenesis of diabetic nephropathy. The present study aimed to determine the extent of the interaction between iron and type 2 diabetes in the kidney. Male rats were randomly assigned into four groups: control, iron (300-mg/kg iron dextran), diabetes (a single dose of intraperitoneal streptozotocin), and iron + diabetes group. Iron supplementation resulted in a higher liver iron content, and diabetic rats showed higher serum glucose compared with control rats, which confirmed the model as iron overload and diabetic. It was found that iron + diabetes group showed a greater degree of kidney pathological changes, a remarkable reduction in body weight, and a significant increase in relative kidney weight and iron accumulation in rat kidneys compared with iron or diabetes group. Moreover, malondialdehyde values in the kidney were higher in iron + diabetes group than in iron or diabetes group, sulfhydryl concentration and glutathione peroxidase activity were decreased by the diabetes and iron + diabetes groups, and protein oxidation and nitration levels were higher in the kidney of iron + diabetes group as compared to iron or diabetes group. However, iron supplementation did not elevate the glucose level of a diabetic further. These results suggested that iron increased the diabetic renal injury probably through increased oxidative/nitrative stress and reduced antioxidant capacity instead of promoting a rise in blood sugar levels; iron might be a potential cofactor of diabetic nephropathy, and strict control of iron would be important under diabetic state.
Li M, Zhao S, Liu Y, Wang Q, Chen Y, Zhou Y Diabetes Metab Syndr Obes. 2024; 17:4105-4113.
PMID: 39502451 PMC: 11537185. DOI: 10.2147/DMSO.S489536.
Dietary iron intake predicts all-cause and cardiovascular mortality in patients with diabetes.
Yang C, Hu T, Li C, Gong A Nutr Diabetes. 2024; 14(1):68.
PMID: 39179569 PMC: 11343882. DOI: 10.1038/s41387-024-00286-2.
Advances of Iron and Ferroptosis in Diabetic Kidney Disease.
Chu J, Wang K, Lu L, Zhao H, Hu J, Xiao W Kidney Int Rep. 2024; 9(7):1972-1985.
PMID: 39081773 PMC: 11284386. DOI: 10.1016/j.ekir.2024.04.012.
Zhao P, Lv X, Zhou Z, Yang X, Huang Y, Liu J Front Endocrinol (Lausanne). 2024; 14:1297166.
PMID: 38189040 PMC: 10767668. DOI: 10.3389/fendo.2023.1297166.
Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy.
Wei M, Liu X, Tan Z, Tian X, Li M, Wei J Front Endocrinol (Lausanne). 2023; 14:1188003.
PMID: 37361521 PMC: 10289168. DOI: 10.3389/fendo.2023.1188003.